Regulators Investigate Stake.com Over Alleged Violations
July 2, 2025 — Sydney, Australia: Crypto casino giant Stake.com is reportedly under investigation by Australian regulatory authorities following allegations that it violated local gambling advertising laws and offered crypto-based games without appropriate licensing.
Why It Matters
Stake.com, one of the most recognized crypto gambling brands globally, has faced increasing scrutiny in multiple jurisdictions. This latest probe adds Australia to the list of countries now monitoring the company's compliance practices.
“Any operator targeting Australian users must adhere to our gambling codes and licensing protocols — crypto or not,” said a spokesperson from AUSTRAC.
Details of the Investigation
- Unlicensed operation targeting Australian residents
- Crypto payments and withdrawals without transparency
- Promotion of gambling to underage users via influencers
What Could Happen Next?
Authorities may issue fines, request account bans, or initiate a geo-blocking order against Stake.com’s Australian user base. Past enforcement actions against international casinos have resulted in millions in penalties.
Global Impact: Will Other Countries Follow?
While this case is localized, it could have broader implications:
| Country | Status | Crypto Gambling Regulation |
|---|---|---|
| Australia | Under Investigation | No formal crypto licensing framework |
| UK | Flagged Stake.com earlier | Strict licensing required for fiat and crypto |
| Germany | Blacklisted Stake.com in 2023 | No tolerance for unlicensed casinos |
| Canada | Gray zone | Allowed in offshore provinces like Ontario |
What Stake.com Has Said
Stake.com’s PR team issued a short statement, saying they are “cooperating fully with authorities and remain confident that all operations comply with local requirements.”
Final Take
This case highlights the growing tension between crypto casinos and national regulators. For players in Australia, caution is advised when accessing offshore operators — especially those under review.